Clinical Trials Browser

Phase 3 × Colorectal Neoplasms × Injections × Clear all

NCT03511963 2024-12-31

A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC

Phase 3 Completed

Gastrointestinal

Colorectal Neoplasms